Baidu
map

The Lancet Psychiatry:孕酮治疗可卡因成瘾?

2014-11-03 MedSci MedSci原创

可卡因因其强烈的中枢神经系统的兴奋作用而导致滥用,可卡因的滥用、成瘾及引起社会的广泛关注。孕酮在药物成瘾的病生理过程中起重要作用,研究表明,可卡因滥用妇女在其内源性孕酮水平较高时期可以减少可卡因的使用量。近期,研究人员在一项随机、双盲、安慰剂对照的前瞻性研究中,初步探讨了可卡因滥用妇女产后服用孕酮是否减少可卡因的使用。 研究方法: 研究人员进行为期12周的双盲、平行、随机、安慰剂对照试验,试验

可卡因因其强烈的中枢神经系统的兴奋作用而导致滥用,可卡因的滥用、成瘾及引起社会的广泛关注。孕酮在药物成瘾的病生理过程中起重要作用,研究表明,可卡因滥用妇女在其内源性孕酮水平较高时期可以减少可卡因的使用量。近期,研究人员在一项随机、双盲、安慰剂对照的前瞻性研究中,初步探讨了可卡因滥用妇女产后服用孕酮是否减少可卡因的使用。

研究方法:

研究人员进行为期12周的双盲、平行、随机、安慰剂对照试验,试验结束后进行3个月随访。受试者为可卡因滥用产妇(产后12周之内)。根据计算机产生的随机序列,受试者随机接受微粉化孕酮(口服,100 mg,每日两次)或安慰剂治疗。主要的试验结果为可卡因的使用情况,即受试者自述的每周服用可卡因的天数和每周可卡因代谢产物尿检阳性次数。这项研究在ClinicalTrials.gov注册,注册号为NCT01249274

研究结果:

研究中共招募50名受试者,其中25名随机纳入安慰几组,25名随机纳入孕酮组。41名(82%)受试者完成试验(20名为孕酮组,21名为安慰剂组)。分析中采纳了所有50名受试者的数据。与孕酮组的受试者相比,安慰剂组的受试者在12周的试验期间可卡因服用自述次数更高(比例为1.1995% CI 1.05—1.36p=0·0097)。然而,若在分析中包括3个月随访期间,两组之间无显著性差异(似然比χ2=5.16p=0·076)。在12周的试验期间及12周试验期间加之3个月随访期间,可卡因的尿检阳性妇女比例在两组无显著性差异。最常见的不良反应为头痛[孕酮组6名(24%),安慰剂组3名(12%]、镇静[每组各4名(16%]、眩晕[孕酮组3名(12%),安慰剂组无]、口干[孕酮组无,安慰剂组3名(12%]和恶心[孕酮组2名(8%)安慰剂组1名(4%]。不良反应的发生率在两组之间无显著性差异。

展望:

上述研究结果提示,可卡因滥用产妇接受孕酮治疗可以减少可卡因的用量,孕酮是否用于可卡因成瘾,还有待于进一步大规模临床试验的佐证。

原始出处:

Kimberly Ann Yonkers, Ariadna Forray, Charla Nich, Kathleen M Carroll, Cristine Hine, Brian C Merry, Howard Shaw, Julia Shaw, Mehmet Sofuoglu. Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot study. The Lancet Psychiatry, Volume 1, Issue 5, Pages 360 - 367, October 2014

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1827912, encodeId=c5bc182e9120d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 17 10:01:00 CST 2015, time=2015-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791889, encodeId=321b1e91889e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jan 22 16:01:00 CST 2015, time=2015-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471022, encodeId=0eaf14e102259, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481677, encodeId=f50014816e7a6, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493787, encodeId=3e1e1493e8767, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=)]
    2015-03-17 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1827912, encodeId=c5bc182e9120d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 17 10:01:00 CST 2015, time=2015-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791889, encodeId=321b1e91889e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jan 22 16:01:00 CST 2015, time=2015-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471022, encodeId=0eaf14e102259, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481677, encodeId=f50014816e7a6, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493787, encodeId=3e1e1493e8767, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1827912, encodeId=c5bc182e9120d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 17 10:01:00 CST 2015, time=2015-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791889, encodeId=321b1e91889e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jan 22 16:01:00 CST 2015, time=2015-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471022, encodeId=0eaf14e102259, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481677, encodeId=f50014816e7a6, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493787, encodeId=3e1e1493e8767, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=)]
    2014-11-05 周虎
  4. [GetPortalCommentsPageByObjectIdResponse(id=1827912, encodeId=c5bc182e9120d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 17 10:01:00 CST 2015, time=2015-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791889, encodeId=321b1e91889e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jan 22 16:01:00 CST 2015, time=2015-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471022, encodeId=0eaf14e102259, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481677, encodeId=f50014816e7a6, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493787, encodeId=3e1e1493e8767, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1827912, encodeId=c5bc182e9120d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 17 10:01:00 CST 2015, time=2015-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791889, encodeId=321b1e91889e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jan 22 16:01:00 CST 2015, time=2015-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471022, encodeId=0eaf14e102259, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481677, encodeId=f50014816e7a6, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493787, encodeId=3e1e1493e8767, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Wed Nov 05 02:01:00 CST 2014, time=2014-11-05, status=1, ipAttribution=)]

相关资讯

爱与美 激活大脑伏隔核:与毒品快感相似

西班牙多所大学的研究人员发现,欣赏一个长得非常漂亮的人,会激活大脑中的许多区域,其中包括一个叫“伏隔核”的区域,而这一区域还与快感和大多数毒品的成瘾感有关。这项研究结果被刊登在荷兰《神经科学》杂志上。据马德里孔普卢栋大学研究人员马丁·洛埃切斯透露,参与这项研究的有男女各10人,他们每个人都需观看850张照片,并把照片上的人分为特别漂亮、一般和特别丑三类。分类完毕后,研究人员会将经过挑选的照片再次拿

PNAS:中外研究人员揭示酒精成瘾机制

酒精在生物体内的代谢途径酒精能够直接参与大脑新陈代谢的有力证据长期“酗酒”后,酒精在胶质细胞内的代谢速度有显著性提高 日前,来自中国科学院武汉物理与数学研究所徐富强课题组的一项最新研究成果,直观地揭示了酒精作为能源物质直接参与大脑的代谢过程,部分解释了酒精成瘾机制。相关论文发表于近期出版的《PNAS》杂志上。【原文下载】据论文第一作者、课题组成员、副研究员王杰介绍,进入体内的酒精,约10%通过呼

止痛药成瘾:横扫美国的大灾难

     药物依赖成为现代社会一大问题。每年都会有15,000美国人因过度服用处方药而死亡,而这一数字仍在增加。   二十多年来珍妮·斯瓦兹威德(Geni Swartzwelder)都在跟她的女儿希瑟(Heather)玩一场艰苦的躲猫猫游戏。每天,52岁的珍妮会把装着白色药片的瓶子偷走,并藏在一个隐秘的地方。每天,32岁的希瑟都会重新搜寻她的药瓶。多数时候她都能找到

Baidu
map
Baidu
map
Baidu
map